SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES
🇮🇷Iran
- Country
- 🇮🇷Iran
- Ownership
- Private
- Established
- 1961-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.sbmu.ac.ir/
Effect of Cholecalciferol, Soy Isoflavones in Patients With Irritable Bowel Syndrome
Phase 4
Completed
- Conditions
- Irritable Bowel Disease
- Interventions
- Dietary Supplement: Soy isoflavonesDietary Supplement: cholecalciferolDietary Supplement: Placebo of soy isoflavonesDietary Supplement: placebo of cholecalciferol
- First Posted Date
- 2014-01-03
- Last Posted Date
- 2014-11-18
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Target Recruit Count
- 100
- Registration Number
- NCT02026518
- Locations
- 🇮🇷
Gastrointestinal Clinics of Tehran University of Medical Sciences, Tehran, Iran, Islamic Republic of
Success Rate of Anterior Middle Superior Alveolar (AMSA) Nerve Block in Three Different Sites of Injection
Not Applicable
Completed
- Conditions
- Anesthesia; Functional
- Interventions
- Procedure: AMSA nerve block injectio
- First Posted Date
- 2013-12-16
- Last Posted Date
- 2013-12-16
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Target Recruit Count
- 40
- Registration Number
- NCT02012257
Face to Face vs. Group Training Methods on Pulse Rate Taking in Patients With Cardiovascular Diseases.
Not Applicable
- Conditions
- Arrythmia
- Interventions
- Other: Face-to-face trainingOther: Group training
- First Posted Date
- 2013-11-20
- Last Posted Date
- 2013-11-20
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Target Recruit Count
- 300
- Registration Number
- NCT01988064
- Locations
- 🇮🇷
Cardiovascular research center, Modarres hospital., Tehran, Iran, Islamic Republic of
Radiosensitizing and Radioprotectve Effects of Curcumin in Prostate Cancer
Not Applicable
Completed
- Conditions
- Prostate CancerRadiation Therapy
- Interventions
- Dietary Supplement: CurcuminDietary Supplement: Placebo
- First Posted Date
- 2013-08-07
- Last Posted Date
- 2015-11-18
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Target Recruit Count
- 40
- Registration Number
- NCT01917890
- Locations
- 🇮🇷
Oncology and radiotherapy department, Besat Hospital, Tehran, Iran, Islamic Republic of
Safety of Continuing Metformin in Diabetic Patients With Normal Kidney Function Receiving Contrast Media
- First Posted Date
- 2013-06-10
- Last Posted Date
- 2014-06-16
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Target Recruit Count
- 166
- Registration Number
- NCT01873859
- Locations
- 🇮🇷
Cardiovascular research center, Modarres hospital., Tehran, Iran, Islamic Republic of
Myoring Versus Keraring Implantation for Keratoconus
Phase 2
- Conditions
- Keratoconus
- Interventions
- Other: Intrastromal corneal continuous ring (Myoring) implantationOther: intrastromal corneal ring segments (Keraring) implantation
- First Posted Date
- 2013-06-05
- Last Posted Date
- 2013-06-05
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Target Recruit Count
- 23
- Registration Number
- NCT01869517
- Locations
- 🇮🇷
Islamic Republic OF Iran, Tehran, Iran, Islamic Republic of
Promethazine vs. Lorazepam for Treatment of Vertigo
- First Posted Date
- 2013-04-09
- Last Posted Date
- 2013-06-14
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Target Recruit Count
- 210
- Registration Number
- NCT01827293
- Locations
- 🇮🇷
Department of Neurology, Emam Hossein Hospital, Tehran, Nezam Abad, Iran, Islamic Republic of
Combined Intravitreal Fasudil and Bevacizumab for Diabetic Macular Edema
Phase 3
Completed
- Conditions
- Diabetic Macular Edema
- Interventions
- Drug: Intravitreal injection of bevacizumab (Avastin)Drug: Intravitreal injection of fasudil and bevacizumab (Avastin)
- First Posted Date
- 2013-04-04
- Last Posted Date
- 2017-05-11
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Target Recruit Count
- 74
- Registration Number
- NCT01823081
Efficacy and Safety of Oral Sumatriptan Plus Oral Promethazine in Migraine Treatment
Phase 3
Completed
- Conditions
- Migraine With AuraMigraine Without Aura
- Interventions
- Drug: Sumatriptan+Promethazine (SPr)
- First Posted Date
- 2013-03-19
- Last Posted Date
- 2013-07-30
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Target Recruit Count
- 350
- Registration Number
- NCT01814189
- Locations
- 🇮🇷
Department of Neurology, Emam Hossein Hospital, Tehran, Iran, Islamic Republic of
Haloperidol vs. Valproate in Agitation
- First Posted Date
- 2012-12-17
- Last Posted Date
- 2013-01-08
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Target Recruit Count
- 56
- Registration Number
- NCT01750541
- Locations
- 🇮🇷
Department of Emergency Medicine, Imam Hossein Hospital, Tehran, Iran, Islamic Republic of
© Copyright 2025. All Rights Reserved by MedPath